(Received 30 April 1979) Equilibrium-dialysis experiments with "'Fe-labelled Fe (Ill) Iron has a marked tendency to form complexes with a variety of ligands, and this has been exploited in biology to give compounds with different functions. The affinity for ligands depends on the oxidation state of the iron, ferric iron having a particularly high affinity for oxy-ligands, including water. As a result, at physiological pH ferric iron tends to be precipitated as polynuclear 'ferric hydroxide'. The iron-storage compound ferritin is such a polymeric hydrolysate of ferric iron, but the polymer is prevented from precipitation by the presence of a soluble protein coat. The solution chemistry of ferric iron presents both the cell and the experimenter with a problem: how to keep ferric iron soluble and monomeric, so that it can get inside the protein shell of ferritin and bind to it. Fe(II1) can be kept in solution by chelation, but the chelator must not have too high an affinity for the cation or it will not release it to the protein. Very little is known about ferritin biosynthesis, but the evidence suggests that it is a cumulative process starting from empty apoferritin shells (Drysdale & Munro, 1966; Hoy & Harrison, 1976; Lee & Richter, 1977) . One way of getting round the problem of the insolubility of Fe(III) that has been found successful in vitro is to start with ferrous iron (Bielig & Bayer, 1955) . In the presence of apoferritin and 02 or other oxidants ferrous iron is bound by the protein and converted to the ferric hydrolysis polymer, indeed apoferritin accelerates this process (Niederer, 1970; Macara et al., 1972 Macara et al., , 1973 Bryce & Crichton, 1973) . We have made a detailed study of the oxidative formation of ferritin in vitro (Macara et al., 1972 (Macara et al., , 1973 Harrison et al., 1974) , but there is no clear evidence for an oxidative pathway in vivo. If ferritin is formed by this pathway, the question arises as to how Fe(II) is protected from oxidation in the cell before incorporation into ferritin. Several workers Vol. 181 (e.g. Drysdale & Munro, 1966; Hoy & Harrison, 1976) have shown that iron injected as Fe(III) is incorporated into ferritin, but it is uncertain whether or not the iron must undergo reduction and reoxidation during ferritin formation. Hoy & Harrison (1976) also showed that if rat liver ferritin is incubated in vitro with ferric ammonium citrate carrying a 59Fe label then some counts are retained by ferritin. In the present paper we attempt to characterize the binding of Fe(III) by ferritin and apoferritin more fully, since this could provide an alternative or additional means of iron accumulation.
Materials and Methods
Horse spleen ferritin (twice-crystallized, Cd-free) was purchased from Miles Laboratories (Stoke Poges, Slough, Bucks., U.K.). Ferritin fractions of differentironcontents were obtained bycentrifugation through sucrose gradients as described by Hoy & Harrison (1975) . Apoferritin was prepared from ferritin by dialysis against 0.1 M-thioglycollic acid/ 0.1 M-sodium acetate mixture, pH4.25, followed by exhaustive dialysis against glass-distilled water and precipitation with 35 % (w/v) (NH4)2S04. All chemicals were AnalaR grade (BDH Chemicals, Atherstone, Warwickshire, U.K.). Ferric iron in ferritin was measured as its absorbance at 420nm (Al'oF = 100; Treffry Radioactivity was measured in a Triton/toluene scintillation fluid (Turner, 1968) 
Fe(II) uptake
With iron added as Fe(II), iron uptake was measured at 310 or 420nm as described by Macara et al. (1972 Macara et al. ( , 1973 . To provide Fe(II), solutions of Fe(NH4)2(SO4)2 were prepared in distilled water through which N2 had been bubbled for 1 h.
Iron release
Rates of iron release were measured in 20mM-sodium acetate/20mM-thioglycollic acid solution adjusted to pH 5.0. The reaction mixture contained 6.4mM-aa-bipyridine and the iron released was measured as the absorbance at 520nm of its bipyridine complex.
Patterns of release of 59Fe and total iron were studied with the aid of an ultrafiltration cell as described by Treffry & Harrison (1978 ( (mg/ml) (Spiro et al., 1967) .
In a parallel experiment the binding of labelled citrate followed a pattern similar to that of Fe(III). (Fig. 3a) or Fe(III) atoms bound/Fe atoms present (Fig. 3b) . The upper curves are the results obtained in equilibriumdialysis experiments in which solutions of fractions (l1O,g of protein/ml) were dialysed against 0.5mm-Fe(III)-citrate in 0.02 M-glycine/NaOH buffer, pH 9.4, containing 0.1 M-NaNO3. The Net binding is expressed in (a) as Fe(l1I) atoms bound/ferritin molecule or in (b) as Fe(llI) atoms bound/ferritin iron atoms. Data points (A) were obtained from equilibrium-dialysis experiments in which ferritin fractions of different iron contents (concn. 150pg of protein/ml) were dialysed for 7 days at 250C against 0.5 mM-Fe(III)-citrate labelled with 59Fe in 20mM-glycine/NaOH buffer, pH9.4, containing 10mM-sodium citrate, lOOmM-NaNO3 and 0.02 %(w/v) NaN3.
Data points (e) were obtained in a separate experiment in which unfractionated ferritin (concn. l50,g of protein/ml) was incubated for 7 days at 25°C with 0.5 mM-Fe(IIl)-citrate labelled with 59Fe in buffer solution as used for equilibrium dialysis. After incubation, unbound Fe(III)-citrate was washed off by ultrafiltration, and the ferritin was then fractionated by density-gradient centrifugation. Samples were analysed for 59Fe and total Fe. citrate ions were retained. The Fe(III) or citrate remaining bound after washing was judged to be inside the ferritin molecule, since the isoelectricfocusing pattern of the protein was unaffected by their presence [isoelectric focusing was carried out by S. M. Russell as described by Russell & Harrison (1978) ].
The binding patterns in Fig. 3 Fig. 4 . As discussed previously (Hoy et al., 1 974b) , if all the "Fe was released first, it should follow line B in Fig. 4 , and the remaining 56Fe release should follow the horizontal line A. Such a theoretical pattern would only be expected if either the added iron was very much more easily removed than that present in the native molecule, or the added iron completely covered the native iron micelle, so that it had to be removed first. The latter condition is more likely to apply to the case when iron was added as Fe(II), since a much larger number of Fe atoms was taken up, and indeed Fig. 4 shows that it more closely approximates to the theoretical model in the initial stages of release. Release patterns would not be expected to follow the simple model after the initial stages, since, once a covering layer of 59Fe has been moved from one part of the micelle, the reagent can release the pre-existing micellar 56Fe. Hence the pattern would be expected to approach the A+B line (the theoretical line for complete isotope mixing) as more Fe was released. The release patterns of Fe added by the two methods are broadly similar, and both suggest the 'last-in-first-out' principle expected for iron added to a micelle, i.e. the added Fe is placed on the micelle surface and does not mix rapidly with Fe already present in the molecule (Hoy et al., 1974b) . Fig. 4 shows that if the preparations are left at 4°C for several days before release is started, the release pattern moves slightly towards the A+B line, suggesting a small extent of exchange of 59Fe and 56Fe atoms. However, complete equilibration did not occur even after 30 days. This result differs from that of Hoy et al. (1974b) , who reported complete mixing after 3 days at 37°C. The difference in results may in part be due to differences in the experimental procedures. Harris (1978) has also found no equilibration of 5"Fe taken up into ferritin micelles after 14 days at 40C when transferrin was the source of Fe. In another experiment release patterns of two reconstituted ferritins were compared (Fig. 5) . In Fig. 5(a) iron was added in the order 56Fe(II) followed by 59Fe(III). In "Fe(II), of 1500 Fe atoms/molecule. Reconstitution was as described in the Materials and Methods section and release as described in Fig. 4 . The theoretical release pattern if the iron was released in order of addition would be CBA. Line A+B+C represents the expected pattern if isotopes were completely mixed.
1979 release was followed, the label was released first in Fig. 5(a) but not in Fig. 5(b) , confirming that in Fig.  5 (b) the radioactive isotope was present in the micelle between two 56Fe layers.
Effect of bound Fe(IlI) on initial rates of release or uptake offurther iron Native ferritin was incubated with Fe(III)-citrate under conditions that gave, after washing, an average of 10% of its iron bound from this source. In a control experiment native ferritin was treated with citrate alone. After washing, the samples were fractionated by sucrose-density centrifugation. Initial rates ofrelease by thioglycollate were estimated spectrophotometrically and the results for the two samples are shown in Fig. 6 . Although there is a considerable amount of scatter in the data, the release rates appear to be the same, i.e. the added iron is not obviously released faster than the native micellar iron. The release patterns in Fig. 6 show a maximum initial rate for fractions containing about 2000 Fe atoms/molecule, or molecules that are approx. one-half full. This result is similar to that previously reported when 1,10-phenanthroline was used for Fe release (Hoy et al., 1974a 
Discussion
Studies by Miller & Perkins (1969) and Harris (1978) have shown that iron can be transferred from transferrin to ferritin in the presence of mediators. Miller & Perkins (1969) found that reducing agents such as ascorbic acid were essential for removal of iron from transferrin and incorporation into ferritin, but that chelators enhanced transfer. Harris (1978) on the other hand has found that transfer can be effected in the absence of reductants, provided that a suitable chelator (citrate or ATP) was present. The net flow, however, was always from ferritin to transferrin in his experiments. Our present experiments show that Fe(III) can be bound by ferritin [from 59Fe(III)-citrate] and, although some Fe(III) was also lost from ferritin under the conditions used, a small net gain of ferric iron occurred. The product closely resembles native ferritin in several respects. We also find that there are some differences in iron incorporation when iron is added as Fe(III), or as Fe(II) in the presence of an oxidant. In the formation of ferritin from apoferritin and Fe(II) the first step is almost certainly the binding of Fe(II) by the protein (Macara et al., 1972 (Macara et al., , 1973 (Fig. 3) also differs, in its dependence on iron content, from that observed with Fe(II) uptake (Harrison et al., 1974) . Fe(III) uptake increased continuously with iron content, whereas Fe(II) uptake was maximal for molecules approximately onethird to one-half full. This may partly be explained if the slow binding of Fe(III) occurs not only on readily available micelle surface sites but if there is time for some Fe(III) to find its way also into some interstitial irregularities or discontinuities between neighbouring crystallites. These factors, in addition to the relatively low number of 59Fe(III) atoms bound compared with 59Fe(II) may contribute to the differences in release patterns shown in Fig. 4 for iron supplied in the two valence states. Iron supplied as Fe(II) most closely follows the 'last-in-first-out' principle (Hoy et al., 1974b) . Williams et al. (1978) have examined by M6ssbauer spectroscopy a single native ferritin fraction containing approx. 2000 Fe atoms (av.) to which a further 200 57Fe(III) atoms were bound from Fe(III)-citrate as described here. According to their results the additional 10% Fe slightly altered the micelle-size distribution compared with the native fraction principally by increasing the size of the smaller particles present.
Our experiments in vitro unfortunately tell us little about how iron is incorporated into ferritin in vivo. They do indicatethat, although Fe(II) may berequired for the initial nucleation stage of ferritin formation (Macara et al., 1972) , some binding of Fe(III) to ferritin is possible. Our experiments also confirm that citrate mediates the slow release of iron from ferritin. Whether there is a net gain or a net loss depends on the interaction of several factors in this complex system. Evidence has been provided that some cellular iron is present as a labile pool (Jacobs, 1977) which may be available for synthesis of haem, iron-containing enzymes or ferritin. It is not known whether this pool is in the form of Fe(II) or Fe(III), although at physiological pH, Fe(III) is the more stable state (Aisen, 1977) . It is possible that ferritin acquires iron from different sources in different forms. Conceivably ferritin could acquire iron alternatively as Fe(II) or Fe(III); for example, it might obtain iron from transferrin after reduction at membrane receptor sites, and Fe(III) could also be added through the chelatable pool. However, much more work needs to be done to establish intracellular iron pathways with confidence.
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